ArticleCureus2026
Dilated Cardiomyopathy in Children: A Diverse Etiological Profile.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Dilated cardiomyopathy (DCM) is the most common form of cardiomyopathy in children and represents a major cause of heart failure and mortality. Its etiological diagnosis often remains complex, particularly in resource-limited settings. Methods This was a retrospective descriptive study conducted over a 26‑month period (February 2024 to April 2026) in the pediatric department of the University Hospital of Tangier, Morocco. All children diagnosed with dilated cardiomyopathy were included. Clinical, etiological, and outcome data were analyzed. Results Among 40 cases of cardiomyopathy, 20 (50%) were dilated cardiomyopathy. The mean age was four years (range: two months to 13 years), with a male predominance (sex ratio = 1.8). All patients were symptomatic at diagnosis. The mean ejection fraction was 34.6%. Mitral regurgitation was observed in 70% of cases, and intracavitary thrombus in 5%. Identified etiologies included myocarditis (15%), genetic causes (15%), aortic coarctation (15%), chronic renal failure (10%), rickets-related hypocalcemia (10%), coronary anomalies (10%), and L‑carnitine deficiency (5%). No etiology was identified in 15% of cases. All patients received heart failure treatment. Mortality was 20%, while 65% of patients showed improvement in cardiac function during follow‑up. Conclusion Dilated cardiomyopathy in children remains a serious condition with multiple etiologies and a non‑negligible mortality rate. Early etiological investigation is essential to guide management and improve prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.